Search Results - "SAITO, Atsuhiro"

Refine Results
  1. 1

    Feasibility, Safety, and Therapeutic Efficacy of Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Sheets in a Porcine Ischemic Cardiomyopathy Model by KAWAMURA, Masashi, MIYAGAWA, Shigeru, OKANO, Teruo, SAWA, Yoshiki, MIKI, Kenji, SAITO, Atsuhiro, FUKUSHIMA, Satsuki, HIGUCHI, Takahiro, KAWAMURA, Takuji, KURATANI, Toru, DAIMON, Takashi, SHIMIZU, Tatsuya

    Published in Circulation (New York, N.Y.) (11-09-2012)
    “…Human induced pluripotent stem cell-derived cardiomyocytes (hiPS-CMs) are a promising source of cells for regenerating myocardium. However, several issues,…”
    Get full text
    Conference Proceeding Journal Article
  2. 2

    Tissue engineered myoblast sheets improved cardiac function sufficiently to discontinue LVAS in a patient with DCM: report of a case by Sawa, Yoshiki, Miyagawa, Shigeru, Sakaguchi, Taichi, Fujita, Tomoyuki, Matsuyama, Akifumi, Saito, Atsuhiro, Shimizu, Tatsuya, Okano, Teruo

    Published in Surgery today (Tokyo, Japan) (01-01-2012)
    “…Dilated cardiomyopathy (DCM) is a heart muscle disease characterized by progressive heart failure, and is a leading cause of mortality and morbidity. Recently,…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Fabrication of natto-structured oxides using metal-EDTA solution by Saito, Atsuhiro, Komatsu, Keiji, Nakamura, Atsushi, Saitoh, Hidetoshi

    Published in Ceramics international (01-06-2021)
    “…We fabricated unique ceramics matrix composites (CMCs) called natto-structured oxides using metal-ethylenediaminetetraacetic acid (EDTA) solution. The…”
    Get full text
    Journal Article
  6. 6

    Phase I Clinical Trial of Autologous Stem Cell-Sheet Transplantation Therapy for Treating Cardiomyopathy by Miyagawa, Shigeru, Domae, Keitaro, Yoshikawa, Yasushi, Fukushima, Satsuki, Nakamura, Teruya, Saito, Atsuhiro, Sakata, Yasushi, Hamada, Seiki, Toda, Koichi, Pak, Kyongsun, Takeuchi, Masahiro, Sawa, Yoshiki

    Published in Journal of the American Heart Association (05-04-2017)
    “…When transplanted into failing heart, autologous somatic tissue-derived cells yield functional recovery via paracrine effects that enhance native regeneration…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    A novel model of chronic limb ischemia to therapeutically evaluate the angiogenic effects of drug candidates by Shimatani, Kenichiro, Sato, Hiromu, Saito, Atsuhiro, Sasai, Masao, Watanabe, Kenichi, Mizukami, Kazuhiko, Kamohara, Masazumi, Miyagawa, Shigeru, Sawa, Yoshiki

    “…Critical limb ischemia (CLI) is a severe state of peripheral artery disease with high unmet clinical needs. Further, there are no effective treatment options…”
    Get more information
    Journal Article
  10. 10
  11. 11
  12. 12

    Immunologic targeting of CD30 eliminates tumourigenic human pluripotent stem cells, allowing safer clinical application of hiPSC-based cell therapy by Sougawa, Nagako, Miyagawa, Shigeru, Fukushima, Satsuki, Kawamura, Ai, Yokoyama, Junya, Ito, Emiko, Harada, Akima, Okimoto, Kaori, Mochizuki-Oda, Noriko, Saito, Atsuhiro, Sawa, Yoshiki

    Published in Scientific reports (27-02-2018)
    “…Induced pluripotent stem cells (iPSCs) are promising candidate cells for cardiomyogenesis in the failing heart. However, teratoma/tumour formation originating…”
    Get full text
    Journal Article
  13. 13

    CXCL4/PF4 is a predictive biomarker of cardiac differentiation potential of human induced pluripotent stem cells by Ohashi, Fumiya, Miyagawa, Shigeru, Yasuda, Satoshi, Miura, Takumi, Kuroda, Takuya, Itoh, Masayoshi, Kawaji, Hideya, Ito, Emiko, Yoshida, Shohei, Saito, Atsuhiro, Sameshima, Tadashi, Kawai, Jun, Sawa, Yoshiki, Sato, Yoji

    Published in Scientific reports (15-03-2019)
    “…Selection of human induced pluripotent stem cell (hiPSC) lines with high cardiac differentiation potential is important for regenerative therapy and drug…”
    Get full text
    Journal Article
  14. 14

    Role and therapeutic effects of skeletal muscle-derived non-myogenic cells in a rat myocardial infarction model by Iseoka, Hiroko, Miyagawa, Shigeru, Saito, Atsuhiro, Harada, Akima, Sawa, Yoshiki

    Published in Stem cell research & therapy (18-02-2020)
    “…Transplantation of skeletal myoblast sheets is a promising strategy for the treatment of heart failure, and its therapeutic effects have already been proven in…”
    Get full text
    Journal Article
  15. 15

    Basic points to consider regarding the preparation of extracellular vesicles and their clinical applications in Japan by Tsuchiya, Atsunori, Terai, Shuji, Horiguchi, Ikki, Homma, Yasuhiro, Saito, Atsuhiro, Nakamura, Norimasa, Sato, Yoji, Ochiya, Takahiro, Kino-oka, Masahiro

    Published in Regenerative therapy (01-12-2022)
    “…In recent years, extracellular vesicles (EVs)11Extracellular vesicles; the positioning paper of the International Society of Extracellular Vesicles (ISEV)…”
    Get full text
    Journal Article
  16. 16
  17. 17

    SVVYGLR motif of the thrombin-cleaved N-terminal osteopontin fragment enhances the synthesis of collagen type III in myocardial fibrosis by Uchinaka, Ayako, Hamada, Yoshinosuke, Mori, Seiji, Miyagawa, Shigeru, Saito, Atsuhiro, Sawa, Yoshiki, Matsuura, Nariaki, Yamamoto, Hirofumi, Kawaguchi, Naomasa

    Published in Molecular and cellular biochemistry (01-10-2015)
    “…Osteopontin (OPN) is involved in various physiological processes such as inflammatory and wound healing. However, little is known about the effects of OPN on…”
    Get full text
    Journal Article
  18. 18

    Influence of coronary architecture on the variability in myocardial infarction induced by coronary ligation in rats by Kainuma, Satoshi, Miyagawa, Shigeru, Fukushima, Satsuki, Tsuchimochi, Hirotsugu, Sonobe, Takashi, Fujii, Yutaka, Pearson, James T, Saito, Atsuhiro, Harada, Akima, Toda, Koichi, Shirai, Mikiyasu, Sawa, Yoshiki

    Published in PloS one (24-08-2017)
    “…It has been shown that the size of myocardial infarction in rats created by coronary ligation technique is not uniform, varying from 4% to 65%. We hypothesized…”
    Get full text
    Journal Article
  19. 19

    Enhanced Pulmonary Vascular and Alveolar Development via Prenatal Administration of a Slow-Release Synthetic Prostacyclin Agonist in Rat Fetal Lung Hypoplasia by Umeda, Satoshi, Miyagawa, Shigeru, Fukushima, Satsuki, Oda, Noriko, Saito, Atsuhiro, Sakai, Yoshiki, Sawa, Yoshiki, Okuyama, Hiroomi

    Published in PloS one (16-08-2016)
    “…Lung hypoplasia and pulmonary hypertension are the major causes of mortality in neonates with congenital diaphragmatic hernia (CDH). Although the prostaglandin…”
    Get full text
    Journal Article
  20. 20

    Development of a vitrification method for preserving human myoblast cell sheets for myocardial regeneration therapy by Ohkawara, Hirotatsu, Miyagawa, Shigeru, Fukushima, Satsuki, Yajima, Shin, Saito, Atsuhiro, Nagashima, Hiroshi, Sawa, Yoshiki

    Published in BMC biotechnology (10-09-2018)
    “…Tissue-engineered cardiac constructs have potential in the functional recovery of heart failure; however, the preservation of these constructs is crucial for…”
    Get full text
    Journal Article